Goldman Sachs’s United States Antimony UAMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$858K Buy
+98,300
New +$857K ﹤0.01% 5202

Other funds holding UAMY

Goldman Sachs's UAMY Position: Q1 2026 in Review

Goldman Sachs reduced its United States Antimony (UAMY) stake by 50% in Q1 2026, selling an estimated $5.85M and leaving 673,872 shares worth $5.88M. The position accounts for ﹤0.01% of the portfolio, ranked #3540.

Goldman Sachs first reported a position in UAMY in Q2 2013 and has held it in 26 quarters since. The position peaked at $6.75M in Q4 2025. 234 funds tracked by Wall St. Rank hold UAMY as of Q1 2026.

  • Goldman Sachs held 673,872 shares of United States Antimony worth $5.88M as of Q1 2026.
  • Goldman Sachs sold 670,908 United States Antimony shares in Q1 2026, an estimated $5.85M.
  • United States Antimony made up ﹤0.01% of Goldman Sachs's portfolio in Q1 2026, its #3540 holding.
  • Goldman Sachs first reported a position in United States Antimony in Q2 2013 and has held it in 26 quarters since.
  • Goldman Sachs's United States Antimony position peaked at $6.75M in Q4 2025.
  • 234 funds tracked by Wall St. Rank held United States Antimony as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.